For Investors
For venture investors, we offer many value-added partnership opportunities including deal sourcing, due diligence, portfolio company support, executive and entrepreneur in residence, syndicate investment, access and join our life sciences and healthcare venture ecosystem.
Deal Sourcing
“This business is about deal flow and cash flow — if you can generate quality deal flow or raise cash from LPs, you are good.”
— Brent Ahrens, Canaan Partners
We have a unique advantage in deal sourcing or deal origination. We have built a strong global network and relationship with many accelerators and incubators, peer investors and venture practitioners, serial entrepreneurs, university and research institution tech transfer offices, corporate spinouts, and professional service providers. In addition, we have built BioVentureOne, a life sciences & healthcare venture ecosystem from which a large volume of venture opportunities continuously flow in. Coupled with our deep understanding of life sciences and healthcare fields, we are able to pre-screen and identify highly promising investment opportunities to feed into your sourcing pipeline.
Due Diligence
“I almost hesitate to use the word due diligence because it implies a certain methodical rigor — rather we ask, what are attributes of successful venture investments”
— Mitch Lasky, Benchmark Capital
Due diligence is the art of sizing up an investment opportunity. Identifying value creation and estimating its sustained advantage is the core of due diligence activity. Our due diligence includes a general “methodical” process and a thorough evaluation of critical attributes. Our general due diligence checklist covers technology and product, business model, market size, management team, competitive advantage, capital efficiency, financials, and exit assumptions. We then deep dive into three key aspects: quality of the entrepreneurs, markets, and technology. We believe the best opportunities should have a healthy mix of all three, and a good assessment of these attributes requires real entrepreneur experience and domain expertise.
Portfolio Company Support
“In the back of my mind, I’m always thinking of introductions…Even if I’m not in meetings I’m thinking of how I can help the company.”
— Jalak Jobanputra, FuturePerfect Ventures
The most promising and successful investors offer value-added support that is as impactful as monetary injections. As a venture partner, we can add value to your portfolio companies in a multitude of ways, in particular:
- Utilize our first-hand entrepreneur experience and rich knowledge in life sciences and healthcare to advise business on strategy, product development and value proposition, commercialization, regulatory approval, medical reimbursement, and operational excellence.
- Leverage our broad network and relationship to help make introductions to prospective customers, thought leaders and industry experts, professional service providers, potential executive talents, and other investors who might partake in future funding rounds.
Entrepreneur in Residence
“An EIR is an all-around athlete who can wear many hats and add value in multiple ways.”
— Neil Kane, Illinois Partners
By leveraging our industry knowledge, real-world entrepreneur experience, life sciences and healthcare domain expertise, and broad network, we partner with venture capital and private equity firms to develop a fundable concept that they can seed, evaluate new investment opportunities, provide operational assistance to existing portfolio companies, and lead an early-stage emerging company to achieve high-growth potential. In addition, we work with institutional funds to nurture expansion, new-product development, or restructuring of a company’s operations, management, or ownership.
Syndicate Investing
“I look for complementary skill sets in syndicate investors so that the combined power of the board is higher in terms of value add.”
— Lip-Bu Tan, Walden International
We embrace syndicate investing not only for meeting the venture’s funding needs, but also for combining intellectual and financial acumen to allow for the better outcomes of the investment opportunity. We especially welcome syndicate investors who share the same philosophy of building a company for the long-term rather than the short-term, show mutual respect, and are willing to come up with a solution that is best for the company. We believe that our deep scientific and technological expertise, entrepreneur experience, and deal sourcing ability are extremely valuable to our syndicate partners.